Literature DB >> 33978742

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.

Emma Biondetti1,2,3, Mathieu D Santin1,2, Romain Valabrègue1,2, Graziella Mangone1,4,5, Rahul Gaurav1,2,3, Nadya Pyatigorskaya1,3,6, Matthew Hutchison7, Lydia Yahia-Cherif1,2, Nicolas Villain1,5, Marie-Odile Habert8,9, Isabelle Arnulf1,3,10, Smaranda Leu-Semenescu10, Pauline Dodet10, Miquel Vila11, Jean-Christophe Corvol1,4,5, Marie Vidailhet1,3,5, Stéphane Lehéricy1,2,3,6.   

Abstract

In Parkinson's disease, there is a progressive reduction in striatal dopaminergic function, and loss of neuromelanin-containing dopaminergic neurons and increased iron deposition in the substantia nigra. We tested the hypothesis of a relationship between impairment of the dopaminergic system and changes in the iron metabolism. Based on imaging data of patients with prodromal and early clinical Parkinson's disease, we assessed the spatiotemporal ordering of such changes and relationships in the sensorimotor, associative and limbic territories of the nigrostriatal system. Patients with Parkinson's disease (disease duration < 4 years) or idiopathic REM sleep behaviour disorder (a prodromal form of Parkinson's disease) and healthy controls underwent longitudinal examination (baseline and 2-year follow-up). Neuromelanin and iron sensitive MRI and dopamine transporter single-photon emission tomography were performed to assess nigrostriatal levels of neuromelanin, iron, and dopamine. For all three functional territories of the nigrostriatal system, in the clinically most and least affected hemispheres separately, the following was performed: cross-sectional and longitudinal intergroup difference analysis of striatal dopamine and iron, and nigral neuromelanin and iron; in Parkinson's disease patients, exponential fitting analysis to assess the duration of the prodromal phase and the temporal ordering of changes in dopamine, neuromelanin or iron relative to controls; and voxel-wise correlation analysis to investigate concomitant spatial changes in dopamine-iron, dopamine-neuromelanin and neuromelanin-iron in the substantia nigra pars compacta. The temporal ordering of dopaminergic changes followed the known spatial pattern of progression involving first the sensorimotor, then the associative and limbic striatal and nigral regions. Striatal dopaminergic denervation occurred first followed by abnormal iron metabolism and finally neuromelanin changes in the substantia nigra pars compacta, which followed the same spatial and temporal gradient observed in the striatum but shifted in time. In conclusion, dopaminergic striatal dysfunction and cell loss in the substantia nigra pars compacta are interrelated with increased nigral iron content.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.

Entities:  

Keywords:  Parkinson’s disease; dopamine transporter; imaging; iron; neuromelanin

Mesh:

Substances:

Year:  2021        PMID: 33978742      PMCID: PMC8634084          DOI: 10.1093/brain/awab191

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  72 in total

1.  Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.

Authors:  Keita Kuya; Yuki Shinohara; Fuminori Miyoshi; Shinya Fujii; Yoshio Tanabe; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2016-01-16       Impact factor: 2.804

2.  Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.

Authors:  R Nandhagopal; L Kuramoto; M Schulzer; E Mak; J Cragg; Chong S Lee; J McKenzie; S McCormick; A Samii; A Troiano; T J Ruth; V Sossi; R de la Fuente-Fernandez; Donald B Calne; A J Stoessl
Journal:  Brain       Date:  2009-08-18       Impact factor: 13.501

3.  Fast free-form deformation using graphics processing units.

Authors:  Marc Modat; Gerard R Ridgway; Zeike A Taylor; Manja Lehmann; Josephine Barnes; David J Hawkes; Nick C Fox; Sébastien Ourselin
Journal:  Comput Methods Programs Biomed       Date:  2009-10-08       Impact factor: 5.428

4.  Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.

Authors:  S Reimão; S Ferreira; R G Nunes; P Pita Lobo; D Neutel; D Abreu; N Gonçalves; J Campos; J J Ferreira
Journal:  Eur J Neurol       Date:  2015-10-31       Impact factor: 6.089

5.  Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.

Authors:  Nadya Pyatigorskaya; Rahul Gaurav; Dario Arnaldi; Smaranda Leu-Semenescu; Lydia Yahia-Cherif; Romain Valabregue; Marie Vidailhet; Isabelle Arnulf; Stephane Lehéricy
Journal:  Sleep       Date:  2017-11-01       Impact factor: 5.849

6.  Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map.

Authors:  Jing Liu; Tian Liu; Ludovic de Rochefort; James Ledoux; Ildar Khalidov; Weiwei Chen; A John Tsiouris; Cynthia Wisnieff; Pascal Spincemaille; Martin R Prince; Yi Wang
Journal:  Neuroimage       Date:  2011-09-08       Impact factor: 6.556

7.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.

Authors:  Andrea Varrone; John C Dickson; Livia Tossici-Bolt; Terez Sera; Susanne Asenbaum; Jan Booij; Ozlem L Kapucu; Andreas Kluge; Gitte M Knudsen; Pierre Malick Koulibaly; Flavio Nobili; Marco Pagani; Osama Sabri; Thierry Vander Borght; Koen Van Laere; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-16       Impact factor: 9.236

8.  Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.

Authors:  Raúl de la Fuente-Fernández; Michael Schulzer; Lisa Kuramoto; Jacquelyn Cragg; Nandhagopal Ramachandiran; Wing L Au; Edwin Mak; Jess McKenzie; Siobhan McCormick; Vesna Sossi; Thomas J Ruth; Chong S Lee; Donald B Calne; A Jon Stoessl
Journal:  Ann Neurol       Date:  2011-01-18       Impact factor: 10.422

9.  Validation of nigrostriatal positron emission tomography measures: critical limits.

Authors:  Morvarid Karimi; LinLin Tian; Christopher A Brown; Hubert P Flores; Susan K Loftin; Tom O Videen; Stephen M Moerlein; Joel S Perlmutter
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

10.  Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

Authors:  John T O'Brien; Sean Colloby; John Fenwick; E David Williams; Michael Firbank; David Burn; Dag Aarsland; Ian G McKeith
Journal:  Arch Neurol       Date:  2004-06
View more
  7 in total

1.  Hippocampal Iron Accumulation Impairs Synapses and Memory via Suppressing Furin Expression and Downregulating BDNF Maturation.

Authors:  Xue Bai; Yi Zhang; Yating Zhang; Shanshan Yao; Yiduo Cui; Lin-Hao You; Peng Yu; Yan-Zhong Chang; Guofen Gao
Journal:  Mol Neurobiol       Date:  2022-06-23       Impact factor: 5.682

Review 2.  The Mechanism and Function of Glia in Parkinson's Disease.

Authors:  Xinguo Zhang; Ruiqi Zhang; Maher Un Nisa Awan; Jie Bai
Journal:  Front Cell Neurosci       Date:  2022-05-26       Impact factor: 6.147

Review 3.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

4.  Efficacy of Traditional Chinese Exercise in Improving Gait and Balance in Cases of Parkinson's Disease: A Systematic Review and Meta-analysis.

Authors:  Minmin Wu; Qiang Tang; Linjing Wang; Mei Zhang; Wenjing Song; Lili Teng; Luwen Zhu
Journal:  Front Aging Neurosci       Date:  2022-06-30       Impact factor: 5.702

Review 5.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

Review 6.  Prodromal Parkinson's disease: hype or hope for disease-modification trials?

Authors:  Philipp Mahlknecht; Kathrin Marini; Mario Werkmann; Werner Poewe; Klaus Seppi
Journal:  Transl Neurodegener       Date:  2022-02-21       Impact factor: 8.014

Review 7.  The Multifaceted Neurotoxicity of Astrocytes in Ageing and Age-Related Neurodegenerative Diseases: A Translational Perspective.

Authors:  David S Bouvier; Sonja Fixemer; Tony Heurtaux; Félicia Jeannelle; Katrin B M Frauenknecht; Michel Mittelbronn
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.